Abstract:Park et al1Park S.W. Lee K.J. Chung M.J. et al.Covered versus uncovered double bare self-expandable metal stent for palliation of unresectable extrahepatic malignant biliary obstruction: a randomized controlled multicenter trial.Gastrointest Endosc. 2023; 97: 132-142.e2Abstract Full Text Full Text PDF Scopus (2) Google Scholar reported no significant differences in the 6-month stent patency rates and mortality between partially covered and uncovered double bare self-expandable metal stents (PCDBSs vs UCDBSs) for unresectable distal malignant biliary obstruction. This randomized controlled multicenter trial is of great significance for clinical practice, yet we would like to share our reservations for further research. First, as shown in the baseline characteristics section, the length of the stricture was longer in PCDBSs than in UCDBSs (2.8 ± 1.3 vs 2.4 ± 1.2, P = .010). The length or the degree of stricture might be correlated with disease severity and stent patency,2Kim H.S. Lee D.K. Kim H.G. et al.Features of malignant biliary obstruction affecting the patency of metallic stents: a multicenter study.Gastrointest Endosc. 2002; 55: 359-365Abstract Full Text Full Text PDF PubMed Scopus (92) Google Scholar and longer biliary stricture was an independent risk factor for worse survival after metal stent insertion,3Zu Q.Q. Zhang J.X. Wang B. et al.Percutaneous transpapillary biliary stent placement for distal malignant biliary obstruction: outcomes and survival analysis.Turk J Gastroenterol. 2019; 30: 714-721Crossref Scopus (5) Google Scholar which is also in accord with the fact that the rate of tumor overgrowth was higher in the PCDBS group than in the UCDBS group (5.5% vs 0.8%). Therefore, we hypothesize that the PCDBS group had selection bias, which would weaken the effect of PCDBSs on stent patency and overall survival, and a propensity-matching analysis may be required. Second, we would like to know whether there was a significant difference in the total incidence of single adverse events between the 2 groups, regardless of the 2-week time limit, so as to better verify the overall impact of whether or not the novel metal stent is covered on the risk of adverse events.4Dumonceau J.M. Kapral C. Aabakken L. et al.ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline.Endoscopy. 2020; 52: 127-149Crossref PubMed Scopus (331) Google Scholar Third, the authors did not disclose the details of revision for stent dysfunction, which might have had some influence on stent patency and overall survival. For example, radiofrequency ablation can be performed by both endoscopic and percutaneous routes. As a novel adjunctive procedure and a promising therapeutic option in patients with malignant biliary obstruction, radiofrequency ablation can achieve local tumor control, resulting in improved biliary stent patency and a potential survival benefit.5Inoue T. Yoneda M. Updated evidence on the clinical impact of endoscopic radiofrequency ablation in the treatment of malignant biliary obstruction.Dig Endosc. 2022; 34: 345-358Crossref PubMed Scopus (22) Google Scholar Both authors disclosed no financial relationships.

Comparison of fully versus partially covered metal stents in endoscopic ultrasound‐guided hepaticogastrostomy for malignant biliary obstruction (with video)

Comparison of long-term outcomes of endoscopic ultrasound-guided hepaticogastrostomy and choledochoduodenostomy for distal malignant biliary obstruction: a multicenter retrospective study

Metal stent versus plastic stent in endoscopic ultrasound‐guided hepaticogastrostomy for unresectable malignant biliary obstruction: Large single‐center retrospective comparative study

Endoscopic ultrasound-guided hepaticogastrostomy versus hepaticogastrostomy with antegrade stenting in patients with unresectable malignant distal biliary obstruction: a propensity score-matched case-control study

Double Bare Self-Expandable Metal Stent for Distal Malignant Biliary Obstruction.

Outcomes of multi-hole self-expandable metal stents versus fully covered self-expandable metal stents for malignant distal biliary obstruction in unresectable pancreatic cancer

Comparison of the efficacy and safety of endoscopic ultrasound‐guided choledochoduodenostomy and hepaticogastrostomy for malignant distal biliary obstruction: Multicenter, randomized, clinical trial

Multicenter study comparing EUS‐guided hepaticogastrostomy and ERCP for malignant biliary obstruction in patients with accessible papillae

Comparison of fully-covered vs partially covered self-expanding metallic stents for palliative treatment of inoperable esophageal malignancy: a systematic review and meta-analysis

Long‐term outcomes of endoscopic ultrasound‐guided hepaticogastrostomy in patients with malignant biliary obstruction

EUS- Versus ERCP-guided Biliary Drainage for Malignant Biliary Obstruction: Evidence from Randomized Controlled Studies

Optimal stent placement strategy for malignant hilar biliary obstruction: a large multicenter parallel study

Efficacy and safety of covered versus uncovered self‑expandable metal stents for the palliative treatment of malignant distal biliary stricture: A long‑term retrospective study

Comparison of an Inside Stent and a Fully Covered Self-Expandable Metallic Stent as Preoperative Biliary Drainage for Patients with Resectable Perihilar Cholangiocarcinoma

Retrospective comparison of different percutaneous approaches to manage occluded primary uncovered self-expandable metal stents in patients with unresectable malignant hilar biliary obstruction.

Comparison between Endoscopic Ultrasound-Guided Antegrade and Transluminal Stent Implantation in Distal Malignant Biliary Obstruction after Failed ERCP

Optimizing EUS-guided choledochoduodenostomy with lumen-apposing metal stents for primary drainage of malignant distal biliary obstruction (SCORPION-IIp): a prospective pilot study

Fully vs. partially covered selfexpandable metal stent for palliation of malignant esophageal strictures: a randomized trial (the COPAC study)

Differences in Efficacy of Uncovered Self-Expandable Metal Stent in Relation to Placement in the Management of Malignant Distal Biliary Obstruction

Efficacy and safety of a novel polytetrafluoroethylene-coated self-expandable metal stent for distal malignant biliary obstruction

Covered self-expandable metallic stent versus plastic stent for preoperative endoscopic biliary drainage in patients with pancreatic cancer: a multi-center retrospective cohort study